Pressing tasks for new director general also include an expiring royal charter, and finding a new top team Matt Brittin may have only just been announced as the new BBC director general, but his inbox is already overflowing. Here are his immediate challenges: Continue reading...
Pressing tasks for new director general also include an expiring royal charter, and finding a new top team Matt Brittin may have only just been announced as the new BBC director general, but his inbox is already overflowing. Here are his immediate challenges: Continue reading...
After almost two decades at Google, the corporation’s incoming director general is taking on British media’s most powerful and treacherous job In recent months, Matt Brittin, the Doctor Who-loving fitness fanatic and former Google executive, has made no secret of his desire to make the jump from big tech to the world of broadcasting. At the end of last year, he told an event filled with some of te...
After almost two decades at Google, the corporation’s incoming director general is taking on British media’s most powerful and treacherous job In recent months, Matt Brittin, the Doctor Who-loving fitness fanatic and former Google executive, has made no secret of his desire to make the jump from big tech to the world of broadcasting. At the end of last year, he told an event filled with some of television’s most senior figures that he had wanted to break into their industry “for a very long time”. Continue reading...
The Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) stands as one of the most popular dividend-growth vehicles on the market. Since its inception on October 20, 2011, the fund has delivered a cumulative total return of 478%, equating to a 13.3% annualized average. With a current yield of 3.3%, SCHD has turned a hypothetical $10,000 investment ... SCHD Just Made Big Changes. Is This Dividend Growth...
The Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) stands as one of the most popular dividend-growth vehicles on the market. Since its inception on October 20, 2011, the fund has delivered a cumulative total return of 478%, equating to a 13.3% annualized average. With a current yield of 3.3%, SCHD has turned a hypothetical $10,000 investment ... SCHD Just Made Big Changes. Is This Dividend Growth ETF Still a Buy?
CRWV wins Zonos deal to power AI-driven cross-border commerce, expanding enterprise SaaS reach and building recurring revenue from multi-year AI cloud deals.
CRWV wins Zonos deal to power AI-driven cross-border commerce, expanding enterprise SaaS reach and building recurring revenue from multi-year AI cloud deals.
Alex Wong/Getty Images News U.S. President Donald Trump has appointed some of the biggest names in business, including Meta Platforms' ( META ) CEO Mark Zuckerberg, Oracle's ( ORCL ) Executive Chairman Larry Ellison, and Nvidia's ( NVDA ) CEO Jensen Huang, to a technology panel to advise him on science and technology. The White House said that under Trump, the President’s Council of Advisors on Sc...
Alex Wong/Getty Images News U.S. President Donald Trump has appointed some of the biggest names in business, including Meta Platforms' ( META ) CEO Mark Zuckerberg, Oracle's ( ORCL ) Executive Chairman Larry Ellison, and Nvidia's ( NVDA ) CEO Jensen Huang, to a technology panel to advise him on science and technology. The White House said that under Trump, the President’s Council of Advisors on Science and Technology, or PCAST, will focus on topics related to the opportunities and challenges that emerging technologies present to the American workforce and ensure all Americans thrive in the Golden Age of Innovation. PCAST will be co-chaired by David Sacks, who has served as White House AI and crypto czar, and Michael Kratsios, another technology advisor, according to the White House's press release. Trump appointed 13 members, which also include Advanced Micro Devices' ( AMD ) CEO Lisa Su and Google's ( GOOG ) ( GOOGL ) Co-Founder Sergey Brin. The White House said that PCAST may be composed of up to 24 members. Additional members will be appointed in the near future, the White House added. More on Meta and Nvidia Nvidia Stock To See New Growth Catalyst: 35X Faster AI With Groq 3 LPX Nvidia: The Market Is Wrong; It Has To Be AMD May Have More Upside Than Nvidia (Upgrade) Exxon Mobil tops Nvidia in valuation amid the ongoing Middle East conflict Meta launches small business initiative to boost entrepreneurship, AI adoption
Former Olympic rower to lead corporation as it hammers out future funding model with government Matt Brittin, Google’s former top executive in Europe, has been named the BBC ’s next director general. Brittin, who stepped down as Google’s president in Europe, the Middle East and Africa last year, will replace Tim Davie at a crucial time for the corporation, as it hammers out its future funding mode...
Former Olympic rower to lead corporation as it hammers out future funding model with government Matt Brittin, Google’s former top executive in Europe, has been named the BBC ’s next director general. Brittin, who stepped down as Google’s president in Europe, the Middle East and Africa last year, will replace Tim Davie at a crucial time for the corporation, as it hammers out its future funding model with the government. Continue reading...
solarseven/iStock via Getty Images U.S. large-cap financial stocks have had a weak start to 2026, with the S&P 500 Financials sector down roughly 8% year-to-date through mid‑March, making it one of the worst-performing major sectors despite relatively solid fundamentals. In such a scenario, we look at the top 10 large-cap financial stocks ranked by their Year-to-Date performance. The list focuses ...
solarseven/iStock via Getty Images U.S. large-cap financial stocks have had a weak start to 2026, with the S&P 500 Financials sector down roughly 8% year-to-date through mid‑March, making it one of the worst-performing major sectors despite relatively solid fundamentals. In such a scenario, we look at the top 10 large-cap financial stocks ranked by their Year-to-Date performance. The list focuses exclusively on the financial sector and includes companies with significant market capitalizations. The list is topped by Tradeweb Markets ( TW ), with a YTD performance of 14.68%. Cboe Global Markets, Inc. ( CBOE ) and CME Group Inc. ( CME ) follow closely behind, demonstrating strong gains in the financial exchanges and data industry. Webster Financial Corporation ( WBS ) rounds out the top four with a 9.10% YTD return. While most stocks on the list carry a “Hold” quant rating, Interactive Brokers Group, Inc. ( IBKR ) stands out with a “Buy” rating of 4.09. M&T Bank Corporation ( MTB ) also holds a “Buy” rating at 3.80, making these two regional bank and brokerage names notable considerations for investors seeking both performance and favorable analyst sentiment. Here is the list: Tradeweb Markets Inc. ( TW ), YTD perf: 14.68%, Quant rating: 3.33 Cboe Global Markets, Inc. ( CBOE ), YTD perf: 12.78%, Quant rating: 3.41 CME Group Inc. ( CME ), YTD perf: 10.84%, Quant rating: 3.44 Webster Financial Corporation ( WBS ), YTD perf: 9.10%, Quant rating: 3.24 Interactive Brokers Group, Inc. ( IBKR ), YTD perf: 2.81%, Quant rating: 4.09 Northern Trust Corporation ( NTRS ), YTD perf: 2.77%, Quant rating: 3.40 Loews Corporation ( L ), YTD perf: 1.74%, Quant rating: Not Covered The Bank of New York Mellon Corporation ( BK ), YTD perf: 1.56%, Quant rating: 3.43 M&T Bank Corporation ( MTB ), YTD perf: 1.14%, Quant rating: 3.80 The Travelers Companies, Inc. ( TRV ), YTD perf: 1.02%, Quant rating: 3.33 Financials ETFs: ( XLF ), ( VFH ), ( IYF ), ( FNCL ), ( IYG ), and ( FXO ) More on fin...
skynesher/E+ via Getty Images ADMA Biologics ( ADMA ) responded to a short report from Culper Research, saying the item appears to contain misleading and inaccurate statements. The short report " appears premised on speculative assertions derived from unidentified and unreliable sources and contains numerous misleading, false and inaccurate statements," ADMA said in a statement on Wednesday. "Desp...
skynesher/E+ via Getty Images ADMA Biologics ( ADMA ) responded to a short report from Culper Research, saying the item appears to contain misleading and inaccurate statements. The short report " appears premised on speculative assertions derived from unidentified and unreliable sources and contains numerous misleading, false and inaccurate statements," ADMA said in a statement on Wednesday. "Despite the conjecture pervading the Short Report, ADMA is taking appropriate steps to review the assertions." Shares of ADMA ( ADMA ) fell 17% on Tuesday following the Culper short report. ADMA has short interest of 8%. More on ADMA Biologics ADMA Biologics, Inc. (ADMA) Q4 2025 Earnings Call Transcript ADMA Biologics: Business Update And My Price Target ADMA Biologics, Inc. (ADMA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript ADMA Biologics announces $125M accelerated share repurchase with JPmorgan ADMA forecasts $635M revenue for 2026 as ASCENIV drives margin expansion and new supply deals extend growth runway